Alivus Life Sciences Acquires 9.21% Stake

LIFE SCIENCES: Alivus Life Sciences Ltd. has acquired a 9.21% stake in Torrent Urja 19 Private Limited for approximately ₹14.04 crore. The investment is aimed at increasing the company’s renewable energy share and supporting compliance with applicable requirements under the Electricity Act. The acquisition provides Alivus Life Sciences with an interest in an entity associated with renewable energy, aligning with the company’s efforts to increase the contribution of renewable sources to its overall energy consumption. Renewable energy procurement and participation in related projects can also form part of corporate initiatives aimed at improving energy efficiency and supporting sustainability objectives. The investment is expected to contribute towards the company’s renewable energy requirements while addressing applicable regulatory and electricity-related requirements. The transaction represents a capital deployment of ₹14.04 crore for the 9.21% stake, with the overall impact on the company’s operations and financial performance depending on the utilisation and benefits associated with the investment. Market participants may track subsequent company disclosures for further details regarding the investment, renewable energy arrangements and the company’s broader sustainability initiatives. This information is shared strictly as a corporate and market update for informational purposes and should not be considered investment advice, research analysis, or a recommendation to buy or sell any security.